Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients

Diabetes Care

Volumn 22, Issue 1, 1999, Pages 152-156

  Watanabe, Naoya ^a   Yoneda, Naoto ^a   Taniguchi, Takahiro ^b   Kurimoto, Yasuyuki ^a   Taketoh, Hiroaki ^a   Yamada, Shigenobu ^a   Kitagawa, Yasuo ^a   Ishikawa, Yuichi ^b   Namura, Hiroyuki ^a  

^a YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPOPROTEINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; TRIGLYCERIDES;

EID: 0345320405     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.1.152     Document Type: Article

References (25)

1. Havel RJ, Rappaport E: Management of hyperlipidemia. N Engl J Med 332:1491-1498, 1995
2. Havel RJ: Biology of cholesterol, lipoproteins and atherosclerosis. Clin Exp Hypertens 11:887-900, 1989
3. Van Gaal LF, Zhang A, Steijaert MM, De Leeuw IH: Human obesity: from lipid abnormalities to lipid oxidation. Int J Obes Relat Metab Disord 19:S21-S26, 1995
4. Castelli WP: Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 70:3H-9H, 1992
5. Assmann G, Schulte H: Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am J Cardiol 70:10H-13H, 1992
6. Phillips NR, Waters D, Havel RJ: Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88:2762-2760, 1993
7. Waters D, Graven TE, Lesperance J: Prognostic significance of progression of coronary atherosclerosis. Circulation 87:1067-1075, 1993
8. Florén C-H, Albers JJ, Bierman EL: Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochem Biophys Acta 663:336-349, 1981
9. Campos E, Nakajima K, Tanaka A, Havel RJ: Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33:369-380, 1992
10. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like lipoproteins in human serum monoclonal anti-apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 223:53-71, 1993
11. Ordovas JK, Wilson PWF, Cupples LA, McNamara JR, Schaefer EJ: Lipids and lipoproteins as risk factors for atherosclerosis: new biochemical and genetic markers (Abstract). Atherosclerosis 134:11-12, 1997
12. Bierman EL: Atherogenesis in diabetes. Arterioscler Thomb 12:647-656, 1992
13. Piedrola G, Novo E, Serrano-Gotarredona J, Escobar-Morreale HF, Villa E, Luna JD, Garcia-Robles R: Insulin resistance in patients with a recent diagnosis of coronary artery disease. J Hypertens 14:1477-1482, 1996
14. Laakso M: Insulin resistance and coronary heart disease. Curr Opin Lipidol 7:217-226, 1996
15. Sugiuti H, Okabe H, Irie T, Uekama K: Differential effect of modified cyclodextrins on serum lipoproteins: applications to direct measurement of high-density lipoprotein in serum. In Proceedings of the 7th International Symposium on Cyclodexrins. Tokyo, Komiyama, 1994 p. 532-535
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density-lipoprotein cholesterol in plasma. without use of the preparative ultracentrifuge. Clin Chem 16:499-502, 1972
17. Garg A, Grundy SM: Management of dyslipidemia in NIDDM. Diabetics Care 13:153-169, 1990
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group, Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
20. Akuzawa K, Nakano T, Sekiguchi I, Shimoyama M, Adachi M, Tange S, Tanaka A, Tada N, Nakajima K: Remnant-like particles-cholesterol (RLP-C) assay and its clinical application to lipid tests in postprandial as well as fasting state. Jpn J Clin Pathol 43:1159-1167, 1995
21. Saniabadi AR, Takeichi S, Yukawa N, Nakajima Y, Umemura K, Nakashima M: Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report. Thromb Haemost 79:878-879
22. Weisgraber K: Apolipoprotein E structure-function relationships. Adv Protein Chem 45:249-302, 1995
23. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988
24. Ginsberg J, Olefsky JM, Reaven GM: Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes 23:674-648, 1974
25. Ginsberg J, Kimerling G, Olefsky JM, Reaven GM: Demonstration of insulin resistance with fasting hyperglycemia. J Clin Invest 55:454-461, 1975